Literature DB >> 1637516

Insulin resistance and abnormal electrocardiograms in patients with high blood pressure.

W H Sheu1, C Y Jeng, S M Shieh, M M Fuh, D D Shen, Y D Chen, G M Reaven.   

Abstract

Plasma glucose and insulin responses to an oral glucose challenge and fasting plasma lipid and lipoprotein concentration were compared in 25 normal individuals and 53 patients with high blood pressure. Patients with hypertension were further subdivided into two groups--normal electrocardiogram (EKG) (n = 24) or abnormal EKG (n = 29)--using the Minnesota code criteria. Patients with hypertension and an abnormal EKG had significantly higher plasma glucose and insulin concentrations following oral glucose than did the control population. Furthermore, plasma triglyceride (TG) concentration was higher and high density lipoprotein cholesterol concentration lower then normal in hypertensive patients with an abnormal EKG, and the ratio of total to HDL cholesterol was higher in this subgroup. Values for patients with high blood pressure and a normal EKG were intermediate. Insulin-mediated glucose uptake was also measured in a subset of patients with hypertension and either a normal (n = 18) or abnormal (n = 17) EKG. When these two subgroups were compared, those with high blood pressure and an abnormal EKG were significantly more insulin resistant than patients with hypertension and a normal EKG. In addition, they also had higher plasma glucose and insulin responses to oral glucose, higher fasting plasma triglyceride and cholesterol concentrations, and an increase in the ratio of total to HDL cholesterol. Thus, patients with high blood pressure have abnormalities of glucose, insulin, and lipid metabolism when compared to a nonhypertensive control group, and the magnitude of these metabolic defects is significantly greater in patients with high blood pressure who have EKG evidence of coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1637516     DOI: 10.1093/ajh/5.7.444

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  7 in total

1.  Relationship among 25-hydroxyvitamin D concentrations, insulin action, and cardiovascular disease risk in patients with essential hypertension.

Authors:  Fahim Abbasi; David Feldman; Michael P Caulfield; Feras M Hantash; Gerald M Reaven
Journal:  Am J Hypertens       Date:  2014-08-19       Impact factor: 2.689

Review 2.  Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease.

Authors:  G M Reaven; A Laws
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

3.  Targeted SERCA2a gene expression identifies molecular mechanism and therapeutic target for arrhythmogenic cardiac alternans.

Authors:  Michael J Cutler; Xiaoping Wan; Kenneth R Laurita; Roger J Hajjar; David S Rosenbaum
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-12

4.  Evidence of higher insulin resistance in NIDDM patients with ischaemic heart disease.

Authors:  S Inchiostro; G Bertoli; G Zanette; V Donadon
Journal:  Diabetologia       Date:  1994-06       Impact factor: 10.122

Review 5.  Relationships among insulin resistance, type 2 diabetes, essential hypertension, and cardiovascular disease: similarities and differences.

Authors:  Gerald M Reaven
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-04       Impact factor: 3.738

6.  Abnormal cation exchange in insulin-resistant patients with essential hypertension.

Authors:  D R Taylor; J R Wing; M I Sonnekus; M Toman; F J Milne
Journal:  Cardiovasc J Afr       Date:  2008 Mar-Apr       Impact factor: 1.167

Review 7.  Insulin resistance, hypertension, and coronary heart disease.

Authors:  Gerald Reaven
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Jul-Aug       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.